DIRECTORY OF ACCREDITED CLINICAL CHAIRS

China's Foremost Medical Specialists & Chief Surgeons

Direct international consultation access to Chinese Academy of Engineering academicians, university hospital presidents, and principal investigators leading national oncology clinical trials. Every specialist maintains internationally published clinical volume in high-complexity oncological surgery, advanced radiotherapy, and cellular therapeutics.

Chief Surgical Oncology & MDT Clinical Consultation
National Surgical Oncology & MDT
Top 1%
National Medical Specialists
18,000+
Annual Neurosurgical Procedures
85%+
Functional Preservation Rate
24–48h
International Triage SLA
ACCREDITED CHIEF SPECIALISTS

China's Leading Medical Oncologists & Surgical Specialists

Direct consultation access to national academic council chairs, surgical directors, and principal investigators leading landmark oncology breakthroughs across China.

Academician Zhou Liangfu, MD, FACS
Neurosurgery & Skull Base
WFNS Medal of Honour · National Neurosurgery Mentor

Academician Zhou Liangfu, MD, FACS

Member of Chinese Academy of Engineering and honorary president of Huashan Neurosurgical Institute. Pioneer of modern microsurgical neuroanatomy with over 50 years of clinical mastery in complex skull base tumors and vascular malformations.

Prof. Mao Ying, MD, PhD
Neurosurgery & Glioma
President of Huashan Hospital · Chief Neurosurgeon

Prof. Mao Ying, MD, PhD

President of Huashan Hospital and Chairman of Chinese Neurosurgical Society. World pioneer in awake cortical mapping, intraoperative 3.0T MRI guided glioma resections, and personalized immunotherapy for high-grade gliomas.

Prof. Yao Yu, MD, PhD
Glioma MDT & Immunotherapy
Director of Glioma MDT · Molecular Neuro-Oncology

Prof. Yao Yu, MD, PhD

Director of Huashan Glioma Multidisciplinary Center. Specializes in multi-omics molecular profiling, Tumor Treating Fields (TTFields/Optune), and novel clinical trials for recurrent glioblastoma.

Prof. Qin Zhiyong, MD, PhD
Skull Base & Pituitary
Chief of Skull Base Surgery · Pituitary Center Chair

Prof. Qin Zhiyong, MD, PhD

Leading expert in endoscopic endonasal skull base surgery, complex craniopharyngiomas, giant pituitary adenomas, and acoustic neuromas with facial nerve functional preservation.

Prof. Wang Yang, MD, PhD
Radiosurgery & Gamma Knife
Director of Radiosurgery · Gamma Knife Center

Prof. Wang Yang, MD, PhD

Director of Huashan Gamma Knife Center. Over 25 years of experience in frameless stereotactic radiosurgery for brain metastases, meningiomas, and arteriovenous malformations (AVMs).

Prof. Jiang Guoliang, MD
Particle & Heavy Ion Radiotherapy
ASTRO Honorary Fellow · Particle Radiotherapy Pioneer

Prof. Jiang Guoliang, MD

Executive leadership at SPHIC and former President of Fudan Cancer Hospital. Global pioneer in carbon ion and proton beam therapy for inoperable skull base chordomas, chondrosarcomas, and adenoid cystic carcinomas.

Academician Ma Jun, MD, PhD
Nasopharyngeal Carcinoma & IMRT
Member, Chinese Academy of Sciences · Global NCCN Guideline Chair

Academician Ma Jun, MD, PhD

World supreme authority on nasopharyngeal carcinoma (NPC). Led landmark NEJM and Lancet trials defining GP induction chemotherapy and IMRT radiation de-escalation protocols worldwide.

Prof. Wu Yilong, MD, PhD
Thoracic Medical Oncology & EGFR
IASLC Lifetime Science Awardee · Past President of CSCO

Prof. Wu Yilong, MD, PhD

Global luminary in lung cancer targeted therapy. Principal investigator of landmark ADAURA, AURA3, and FLAURA international trials establishing first-line and adjuvant osimertinib standards worldwide.

Academician He Jie, MD, PhD
Thoracic Surgical Oncology
Member, Chinese Academy of Sciences · Director of National Cancer Center

Academician He Jie, MD, PhD

Supreme authority in thoracic surgical oncology. Pioneered standardized McKeown three-incision esophagectomy with three-field lymphadenectomy and complex sleeve lobectomies for central lung cancer.

Academician Xia Qiang, MD, PhD
Liver Transplantation & Hepatic Surgery
Member, Chinese Academy of Engineering · President of Renji Hospital

Academician Xia Qiang, MD, PhD

Director of the world's #1 pediatric liver transplantation center (3,500+ transplants). Renowned for living-donor liver transplantation, microvascular reconstruction, and conversion therapy for advanced liver cancer.

Prof. Ji Jiafu, MD, PhD
Gastric Surgical Oncology
Past President, IGCA · President of PKU Cancer Hospital

Prof. Ji Jiafu, MD, PhD

Pioneer of standardized D2 radical gastrectomy and lead investigator of the RESOLVE trial published in The Lancet Oncology. Global leader in laparoscopic gastrectomy and HIPEC for peritoneal metastasis.

Prof. Wang Weidong, MD
Minimally Invasive Cryoablation
Director of Oncology Center · Specialist in Cryoablation

Prof. Wang Weidong, MD

Master of CT-guided argon-helium cryoablation and microwave thermal ablation for inoperable pulmonary, hepatic, and retroperitoneal tumors, delivering high local control without open surgical trauma.

Prof. Mi Jianqing, MD, PhD
CAR-T Immunotherapy & Hematology
Director of Clinical Hematology · CAR-T Cellular Lead

Prof. Mi Jianqing, MD, PhD

Core investigator at Shanghai Institute of Hematology. Leading clinical trials in tandem CD19/CD22 and BCMA CAR-T cell infusions for refractory lymphoma, leukemia, and multiple myeloma.

Prof. Han Weidong, MD, PhD
Biotherapy & Solid Tumor CAR-T
Director of Biotherapeutic Center · National CAR-T Pioneer

Prof. Han Weidong, MD, PhD

National pioneer in translational CAR-T therapy for both hematologic malignancies and solid tumors (EGFR, Claudin 18.2, CD133), engineering armored CAR constructs to overcome immunosuppression.

Prof. Shao Zhimin, MD, PhD
Breast Surgical Oncology & TNBC
Director of Breast Cancer Institute · Fudan TNBC Pioneer

Prof. Shao Zhimin, MD, PhD

Architect of the internationally recognized 'Fudan Four-Subtype' classification for Triple-Negative Breast Cancer (TNBC). Master of oncoplastic breast-conserving surgery and axillary reverse mapping.

Four Steps to an Accredited Chief Second Opinion

STANDARDIZED INTERNATIONAL CONSULTATION PATHWAY

How international patients connect with top Chinese department chairs, confirm treatment eligibility, and enter fast-track clinical admission without queue delays.
01

Submit Records

Upload cranial MRI/CT DICOM scans, histology pathology slides, and past surgical summaries through our secure portal.

02

Chief & MDT Review

The designated Chief Surgeon and multidisciplinary oncology team formulate an independent surgical and therapeutic roadmap.

03

Formal Written Plan

Receive a bilingual medical report detailing operability, target preservation rates, expected hospital stay, and itemized cost.

04

VIP Hospitalization

Fast-track medical visa invitation, airport concierge transfer, dedicated private suite, and direct admission under the Chief.

PATIENT FAQS

Frequently Asked Questions

Key clinical, logistical, and consultation insights for international patients seeking second opinions and expert surgical care with China’s leading hospital chairs.

Patients upload their cranial MRI/CT DICOM imaging and histological pathology reports. Our clinical coordination desk translates and cross-indexes records into standardized international format and presents them directly to the designated Chief Surgeon and multidisciplinary neuro-oncology board within 24 to 48 hours.
Yes. International patients may request direct case assessment and surgical booking with specific leaders, including Academician Zhou Liangfu, Prof. Mao Ying (Huashan Hospital), Academician Fan Jia (Zhongshan Hospital), or Prof. Lu Shun (Shanghai Chest Hospital). Consultations are arranged through dedicated International Medical VIP Channels.
We require uncompressed raw DICOM imaging files (contrast-enhanced MRI T1/T2/FLAIR, DWI, or thin-slice CT) exported directly from the scanner, official histological pathology reports, immunohistochemical results (e.g. IDH1/2, MGMT, 1p/19q codeletion for gliomas), and past operative summaries.
Upon formal clinical acceptance by the surgical chair, an expedited Medical Treatment Visa (M/S2) invitation is issued within 48 to 72 hours. Patients arriving at Shanghai Pudong or Hongqiao airports are met by medical logistics liaisons and directly admitted to private suites without public triage wait times.
All accredited department chairs have completed long-term clinical fellowships at world-renowned centers (such as Harvard MGH, Mayo Clinic, MD Anderson, or Univ. of Michigan) and communicate fluently in English. Dedicated bilingual medical escorts accompany patients through preoperative planning, awake intraoperative brain mapping, and post-op care.
Formal case evaluation by a Chinese Academy of Engineering academician or department chair is typically $1,500–$3,500 USD (including comprehensive English report and board review). Inpatient surgical deposits and procedural fees are settled directly with the hospital’s international billing office via wire transfer or international credit card with full itemized transparency.

CASE INTAKE & EVALUATION

Request a Confidential Case Review

Please provide your contact information and a concise clinical summary. Our medical coordination team reviews all inquiries within 24–48 hours to assess eligibility for hospital multidisciplinary board evaluation.

    Our Medical Specialists – Accredited Chief Physicians in China